Glibornuride Can Be Fun For Anyone
All enrolled people who acquired at the very least one dose of zosuquidar or placebo in the course of induction were being monitored for your event of adverse gatherings (439 individuals, 219 on zosuquidar and 210 on placebo). The commonest adverse events have been relevant to the duration of extended and major myelosuppression as is anticipated wi